2021
Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation
GIALLONGO, Sebastiano, Daniela ŘEHÁKOVÁ, Marco RAFFAELE, Oriana LO RE, Irena KOUTNÁ et. al.Základní údaje
Originální název
Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation
Autoři
GIALLONGO, Sebastiano (380 Itálie, domácí), Daniela ŘEHÁKOVÁ (203 Česká republika, domácí), Marco RAFFAELE (380 Itálie), Oriana LO RE (380 Itálie), Irena KOUTNÁ (203 Česká republika, domácí) a Manlio VINCIGUERRA (380 Itálie, garant, domácí)
Vydání
ANTIOXIDANTS & REDOX SIGNALING, NEW ROCHELLE, MARY ANN LIEBERT, INC, 2021, 1523-0864
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10608 Biochemistry and molecular biology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 7.468
Kód RIV
RIV/00216224:14110/21:00120673
Organizační jednotka
Lékařská fakulta
UT WoS
000555879000001
Klíčová slova anglicky
induced pluripotent stem cells (iPSCs); oxidative stress; DNA damage
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 24. 10. 2022 10:17, Mgr. Tereza Miškechová
Anotace
V originále
Significance:Since their discovery, induced pluripotent stem cells (iPSCs) had generated considerable interest in the scientific community for their great potential in regenerative medicine, disease modeling, and cell-based therapeutic approach, due to their unique characteristics of self-renewal and pluripotency. Recent Advances:Technological advances in iPSC genome-wide epigenetic profiling led to the elucidation of the epigenetic control of cellular identity during nuclear reprogramming. Moreover, iPSC physiology and metabolism are tightly regulated by oxidation-reduction events that mainly occur during the respiratory chain. In theory, iPSC-derived differentiated cells would be ideal for stem cell transplantation as autologous cells from donors, as the risks of rejection are minimal. Critical Issues:However, iPSCs experience high oxidative stress that, in turn, confers a high risk of increased genomic instability, which is most often linked to DNA repair deficiencies. Genomic instability has to be assessed before iPSCs can be used in therapeutic designs. Future Directions:This review will particularly focus on the links between redox balance and epigenetic modifications-in particular based on the histone variant macroH2A1-that determine DNA damage response in iPSCs and derived differentiated cells, and that might be exploited to decrease the teratogenic potential on iPSC transplantation.
Návaznosti
MUNI/A/1325/2020, interní kód MU |
| ||
90128, velká výzkumná infrastruktura |
|